This systematic review and meta-analysis included data from 2,565,920 women with a history of alcohol consumption. The study assessed the relationship between alcohol intake and breast cancer incidence, recurrence, and survival outcomes. Comparisons were made against no alcohol consumption or varying levels of intake.
The analysis demonstrated a dose-dependent increase in breast cancer incidence. Any alcohol consumption was associated with a relative risk (RR) of 1.17 (95%CI 1.09-1.26). Light consumption showed an RR of 1.13 (95%CI 1.05-1.23), intermediate consumption an RR of 1.28 (95%CI 1.18-1.39), and heavy consumption an RR of 1.52 (95%CI 1.38-1.67).
Regarding survival outcomes, no associations were found for breast cancer recurrences (RR 1.02, 95%CI 0.93-1.11) or breast cancer-specific survival (HR 0.93, 95%CI 0.87-1.00). However, light and intermediate alcohol consumption were associated with slightly improved overall survival, with HRs of 0.85 (95%CI 0.78-0.92) and 0.84 (95%CI 0.75-0.94), respectively.
The findings suggest that while alcohol consumption increases the risk of developing breast cancer, it does not appear to influence recurrence or specific survival rates in this population. The observed improvement in overall survival for light and intermediate consumers requires cautious interpretation given the observational nature of the data.
View Original Abstract ↓
BACKGROUND: While alcohol consumption appears to influence the incidence of breast cancer (BC), its association with prognosis after a BC diagnosis remains less established. This meta-analysis aimed to explore the association between alcohol consumption on both BC incidence and outcomes.
METHODS: A systematic literature search was conducted up to May 1st, 2025 (CRD42025593784). Retrospective and prospective studies reporting BC incidence, recurrences, and survival outcomes in women with history of alcohol consumption were included. Analyses according to alcohol intake levels (light, intermediate, heavy consumption) were performed. Main outcomes were BC incidence, BC recurrences, BC-specific survival (BCSS), and overall survival (OS). Pooled relative risk (RR) and hazard ratio (HR) with 95% confidence interval (CI) were calculated.
RESULTS: Out of 5208 screened records, 37 studies including 2,565,920 women were included. Among 17 studies reporting on BC incidence, any alcohol consumption was associated with an increased BC incidence (RR 1.17, 95%CI 1.09-1.26; p < 0.001). BC incidence increased proportionally with higher levels of alcohol consumption: light RR 1.13 (95%CI 1.05-1.23; p = 0.002), intermediate RR 1.28 (95%CI 1.18-1.39; p < 0.001), and heavy consumption RR 1.52 (95%CI 1.38-1.67; p < 0.001). Among 20 studies assessing BC outcomes, no associations were found between alcohol consumption and BC recurrences (RR 1.02, 95%CI 0.93-1.11) nor BCSS (HR 0.93, 95%CI 0.87-1.00), while light and intermediate alcohol consumption were associated with slightly improved OS: HR 0.85 (95%CI 0.78-0.92; p < 0.001) and HR 0.84 (95%CI 0.75-0.94; p = 0.002), respectively.
CONCLUSIONS: Among over 2.5 million women, alcohol consumption was associated with a dose-dependent increased risk of BC, while alcohol consumption did not appear to worsen prognosis in patients with prior BC diagnosis.